Monika Engelhardt, MD, of the University Medical Center Freiburg, Freiburg, Germany, speaking from the 1st European Myeloma Network (EMN) Meeting 2018, held in Turin, Italy, discusses the cost-effectiveness of multiple myeloma (MM) treatments. She speaks about the expense associated with combination therapies, and the differences in drug costs between countries.
Cost-effectiveness of MM treatment
